These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37221124)

  • 1. Activation, decommissioning, and dememorization: enhancers in a life cycle.
    Wu X; Wu X; Xie W
    Trends Biochem Sci; 2023 Aug; 48(8):673-688. PubMed ID: 37221124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylome inheritance and enhancer dememorization reset an epigenetic gate safeguarding embryonic programs.
    Wu X; Zhang H; Zhang B; Zhang Y; Wang Q; Shen W; Wu X; Li L; Xia W; Nakamura R; Liu B; Liu F; Takeda H; Meng A; Xie W
    Sci Adv; 2021 Dec; 7(52):eabl3858. PubMed ID: 34936444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making connections: enhancers in cellular differentiation.
    Herrmann JC; Beagrie RA; Hughes JR
    Trends Genet; 2022 Apr; 38(4):395-408. PubMed ID: 34753603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancer decommissioning by LSD1 during embryonic stem cell differentiation.
    Whyte WA; Bilodeau S; Orlando DA; Hoke HA; Frampton GM; Foster CT; Cowley SM; Young RA
    Nature; 2012 Feb; 482(7384):221-5. PubMed ID: 22297846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
    Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
    Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancers navigate the three-dimensional genome to direct cell fate decisions.
    Kim J; Dean A
    Curr Opin Struct Biol; 2021 Dec; 71():101-109. PubMed ID: 34280668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread Enhancer Dememorization and Promoter Priming during Parental-to-Zygotic Transition.
    Zhang B; Wu X; Zhang W; Shen W; Sun Q; Liu K; Zhang Y; Wang Q; Li Y; Meng A; Xie W
    Mol Cell; 2018 Nov; 72(4):673-686.e6. PubMed ID: 30444999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancers: emerging roles in cell fate specification.
    Ong CT; Corces VG
    EMBO Rep; 2012 Apr; 13(5):423-30. PubMed ID: 22491032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancers as non-coding RNA transcription units: recent insights and future perspectives.
    Li W; Notani D; Rosenfeld MG
    Nat Rev Genet; 2016 Apr; 17(4):207-23. PubMed ID: 26948815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconfiguration of nucleosome-depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer.
    Taberlay PC; Statham AL; Kelly TK; Clark SJ; Jones PA
    Genome Res; 2014 Sep; 24(9):1421-32. PubMed ID: 24916973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ Super-enhancers. Are they regulators of regulatory genes of development and cancer?].
    Didych DA; Tyulkina DV; Pleshkan VV; Alekseenko IV; Sverdlov ED
    Mol Biol (Mosk); 2015; 49(6):915-22. PubMed ID: 26710770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opening up the blackbox: an interpretable deep neural network-based classifier for cell-type specific enhancer predictions.
    Kim SG; Theera-Ampornpunt N; Fang CH; Harwani M; Grama A; Chaterji S
    BMC Syst Biol; 2016 Aug; 10 Suppl 2(Suppl 2):54. PubMed ID: 27490187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing.
    Yoo KH; Hennighausen L; Shin HY
    J Mammary Gland Biol Neoplasia; 2019 Mar; 24(1):47-59. PubMed ID: 30291498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic Enhancers in Brain Health and Disease.
    Carullo NVN; Day JJ
    Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30646598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Super-enhancers include classical enhancers and facilitators to fully activate gene expression.
    Blayney JW; Francis H; Rampasekova A; Camellato B; Mitchell L; Stolper R; Cornell L; Babbs C; Boeke JD; Higgs DR; Kassouf M
    Cell; 2023 Dec; 186(26):5826-5839.e18. PubMed ID: 38101409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone H3K27ac separates active from poised enhancers and predicts developmental state.
    Creyghton MP; Cheng AW; Welstead GG; Kooistra T; Carey BW; Steine EJ; Hanna J; Lodato MA; Frampton GM; Sharp PA; Boyer LA; Young RA; Jaenisch R
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21931-6. PubMed ID: 21106759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide Maps of Transcription Regulatory Elements and Transcription Enhancers in Development and Disease.
    Agrawal P; Heimbruch KE; Rao S
    Compr Physiol; 2018 Dec; 9(1):439-455. PubMed ID: 30549021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of enhancers embodies shared and representative functional groups underlying developmental and cell type-specific gene regulation.
    Song W; Ovcharenko I
    Gene; 2022 Aug; 834():146640. PubMed ID: 35680026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancer Predictions and Genome-Wide Regulatory Circuits.
    Beer MA; Shigaki D; Huangfu D
    Annu Rev Genomics Hum Genet; 2020 Aug; 21():37-54. PubMed ID: 32443951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissection of thousands of cell type-specific enhancers identifies dinucleotide repeat motifs as general enhancer features.
    Yáñez-Cuna JO; Arnold CD; Stampfel G; Boryń LM; Gerlach D; Rath M; Stark A
    Genome Res; 2014 Jul; 24(7):1147-56. PubMed ID: 24714811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.